← European Medicine Shortage Tracker · all medicines

Basisches magnesiumcarbonat, calciumacetat shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Basisches magnesiumcarbonat, calciumacetat currently has availability issues reported in 1 European register: Austria.

Shortage  ATC V03AE04 · also listed as: BASISCHES MAGNESIUMCARBONAT, CALCIUMACETAT · data refreshed 5 November 2026

Key facts

As of 5 November 2026, 1 of the 10 tracked registers list current availability issues for Basisches magnesiumcarbonat, calciumacetat, covering 1 affected product presentation. The longest-running open report was filed in Austria on 2025-03-20 and has now been open for about 20 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2027-03-31; the earliest is 2027-03-31. In the WHO ATC classification, Basisches magnesiumcarbonat, calciumacetat is coded V03AE04 — a medicine acting on various — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇦🇹 AustriaShortage
OsvaRen 435 mg/235 mg Filmtabletten (PZN 3533300)
2025-03-202027-03-31Qualitätsprobleme des Fertigproduktesregister ↗

Full report history (1 register entry)

Every individual register entry for Basisches magnesiumcarbonat, calciumacetat in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇦🇹 ATOsvaRen 435 mg/235 mg Filmtabletten (PZN 3533300)Shortage2025-03-202027-03-31Qualitätsprobleme des Fertigproduktes

Frequently asked

Is Basisches magnesiumcarbonat, calciumacetat currently in shortage in Europe?

Yes. As of 5 November 2026, availability issues are reported in: Austria. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Basisches magnesiumcarbonat, calciumacetat shortage expected to end?

Agency prognoses on file range from 2027-03-31 to 2027-03-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Where does this Basisches magnesiumcarbonat, calciumacetat availability data come from?

Directly from the official medicines-agency register that lists Basisches magnesiumcarbonat, calciumacetat: BASG (Austria). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Basisches magnesiumcarbonat, calciumacetat — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/basisches-magnesiumcarbonat-calciumacetat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Basisches magnesiumcarbonat, calciumacetat availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/basisches-magnesiumcarbonat-calciumacetat/">Basisches magnesiumcarbonat, calciumacetat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Basisches magnesiumcarbonat, calciumacetat: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 5 November 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.